Irving Kirsch
Irving Kirsch (born March 7, 1943) is an American psychologist and academic. He is the Associate Director of the Program in Placebo Studies and a lecturer in medicine at the Harvard Medical School and Beth Israel Deaconess Medical Center. He is also professor emeritus of psychology at the Universities of Hull and Plymouth in the United Kingdom, and the University of Connecticut in the United States. Kirsch is a leading researcher within the field of placebo studies who is noted for his work on placebo effects, antidepressants, expectancy, and hypnosis. He is the originator of response expectancy theory, and his analyses of clinical trials of antidepressants have influenced official treatment guidelines in the United Kingdom. He is the author of the 2009 book ''The Emperor's New Drugs'', which argued most antidepressant medication is effective primarily due to placebo effects. Provided by Wikipedia
Showing 1 - 20 results of 25 for search 'Irving Kirsch', query time: 0.05s
Refine Results
-
1
Response Expectancy and the Response to Antidepressant Medication by Irving Kirsch
Published 2017-11-01
Article -
2
Placebo Effect in the Treatment of Depression and Anxiety by Irving Kirsch
Published 2019-06-01
Article -
3
Challenging Received Wisdom: Antidepressants and the Placebo Effect by Irving Kirsch
Published 2020-12-01
Article -
4
Expectations: How and when do they contribute to placebo analgesia? by Sophie Rosenkjær, Sigrid Juhl Lunde, Irving Kirsch, Lene Vase
Published 2022-09-01
Article -
5
-
6
-
7
-
8
A systematic review of comparative efficacy of treatments and controls for depression. by Arif Khan, James Faucett, Pesach Lichtenberg, Irving Kirsch, Walter A Brown
Published 2012-01-01
Article -
9
-
10
-
11
-
12
-
13
-
14
Well-loved music robustly relieves pain: a randomized, controlled trial. by Christine Hsieh, Jian Kong, Irving Kirsch, Robert R Edwards, Karin B Jensen, Ted J Kaptchuk, Randy L Gollub
Published 2014-01-01
Article -
15
Beneficial and harmful effects of antidepressants versus placebo, ‘active placebo’, or no intervention for adults with major depressive disorder: a protocol for a systematic review... by Sophie Juul, Faiza Siddiqui, Marija Barbateskovic, Caroline Kamp Jørgensen, Michael Pascal Hengartner, Irving Kirsch, Christian Gluud, Janus Christian Jakobsen
Published 2021-05-01
Article -
16
-
17
Tricyclic antidepressants versus ‘active placebo’, placebo or no intervention for adults with major depressive disorder: a protocol for a systematic review with meta-analysis and T... by Caroline Kamp Jørgensen, Sophie Juul, Faiza Siddiqui, Marija Barbateskovic, Klaus Munkholm, Michael Pascal Hengartner, Irving Kirsch, Christian Gluud, Janus Christian Jakobsen
Published 2021-08-01
Article -
18
-
19
Music-Induced Analgesia in Healthy Participants Is Associated With Expected Pain Levels but Not Opioid or Dopamine-Dependent Mechanisms by Sigrid Juhl Lunde, Peter Vuust, Peter Vuust, Eduardo A. Garza-Villarreal, Eduardo A. Garza-Villarreal, Irving Kirsch, Arne Møller, Arne Møller, Lene Vase
Published 2022-04-01
Article -
20
The risks of adverse events with venlafaxine and mirtazapine versus ‘active placebo’, placebo, or no intervention for adults with major depressive disorder: a protocol for two sepa... by Caroline Kamp Jørgensen, Sophie Juul, Faiza Siddiqui, Mark Abie Horowitz, Joanna Moncrieff, Klaus Munkholm, Michael Pascal Hengartner, Irving Kirsch, Christian Gluud, Janus Christian Jakobsen
Published 2023-03-01
Article